Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

Status Completed

Clinical Trial Summary

Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis

Clinical Trial Description

Miltefosine (42 days) will be used to try to improve upon the cure rate with 28 days of drug for bolivian mucosal leishmaniasisi ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Leishmaniasis

Clinical Trial Details

NCT number	NCT00373568
Study type	Interventional
Source	AB Foundation
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	April 2005
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03641339` - Defining Skin Immunity of a Bite of Key Insect Vectors in Humans	N/A
Completed	`NCT04504435` - Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants	Phase 1
Completed	`NCT00004755` - Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil	Phase 2
Completed	`NCT00657618` - Use of Sodium Stibogluconate as a Treatment for Leishmaniasis	Phase 1/Phase 2
Completed	`NCT04512742` - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies	N/A
Recruiting	`NCT00344188` - Diagnosis and Treatment of Leishmania Infections
Active, not recruiting	`NCT03009422` - Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.	N/A
Recruiting	`NCT05449717` - Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan
Recruiting	`NCT06307171` - Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers	N/A
Completed	`NCT01751048` - LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine	Phase 1
Terminated	`NCT06124144` - Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults	Phase 1
Completed	`NCT00662012` - Sodium Stibogluconate Treatment of Leishmaniasis	Phase 2
Completed	`NCT03993093` - Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
Recruiting	`NCT03784248` - Mediterranean Visceral Leishmaniasis With Leishmania Infantum
Withdrawn	`NCT02429505` - Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Completed	`NCT01377974` - Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis	Phase 2
Completed	`NCT02656797` - Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis	Phase 2
Completed	`NCT01484548` - Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers	Phase 1
Completed	`NCT01300975` - Intralesional Antimony for Bolivian Cutaneous Leishmaniasis	Phase 2
Completed	`NCT03294161` - Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis	Phase 2